Publications by authors named "Matteo Benini"
Article Synopsis
- - Nonketotic hyperglycemic hyperosmolar state (NKHHS) can lead to various neurological issues, including symptoms resembling a stroke, but the exact causes and clinical features are still unclear.
- - A review of 18 cases showed that hemianopia was the most common symptom, and it was more frequently seen in older patients with higher glucose levels, with brain MRIs indicating significant abnormalities in nearly three-quarters of cases.
- - The study suggests that the acute neurological deficits are primarily due to metabolic neuronal dysfunction, and while many patients recover quickly with proper treatment, timely diagnosis is essential to prevent lasting damage.
Introduction Acute cerebral venous thrombosis (CVT) may result in a variety of clinical presentations, with headache being the most common. The relationship between clinical and neuroradiological characteristics in acute CVT patients is still not univocally characterized. Materials and methods We enrolled 32 consecutive acute CVT patients admitted to our emergency department from January 1, 2012, to June 30, 2019.
View Article and Find Full Text PDFBackground: Hypertrophic pachymeningitis (HP) and spontaneous intracranial hypotension are different treatable diseases, which should promptly be recognized and treated to prevent neurologic sequelae. Headache and dural enhancement are the main features of both diseases, thus differentiating between these 2 conditions can be difficult.
Cases Description: We present 2 cases with headache and dural enhancement, in which the differential diagnosis was challenging at presentation because, in both cases, clear positional pain modification was not reported.
Objective: To report clinical and laboratory characteristics, treatment, and clinical outcomes of patients admitted for neurologic diseases with and without coronavirus disease 2019 (COVID-19).
Methods: In this retrospective, single-center cohort study, we included all adult inpatients with confirmed COVID-19 admitted to a neuro-COVID unit beginning February 21, 2020, who had been discharged or died by April 5, 2020. Demographic, clinical, treatment, and laboratory data were extracted from medical records and compared (false discovery rate corrected) to those of neurologic patients without COVID-19 admitted in the same period.